Rafferty Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
134,152
-53,239
-28% -$457K ﹤0.01% 745
2025
Q4
$1.95M Buy
187,391
+74,169
+66% +$778K 0.01% 651
2025
Q3
$1M Buy
113,222
+8,112
+8% +$57.8K ﹤0.01% 790
2025
Q2
$606K Sell
105,110
-25,988
-20% -$159K ﹤0.01% 845
2025
Q1
$865K Sell
131,098
-14,516
-10% -$113K ﹤0.01% 771
2024
Q4
$1.27M Buy
145,614
+53,877
+59% +$775K ﹤0.01% 745
2024
Q3
$1.79M Sell
91,737
-32,848
-26% -$666K 0.01% 671
2024
Q2
$2.57M Sell
124,585
-186,683
-60% -$3.84M 0.01% 577
2024
Q1
$6.64M Buy
311,268
+159,994
+106% +$3.11M 0.02% 397
2023
Q4
$2.18M Sell
151,274
-80,933
-35% -$796K 0.01% 652
2023
Q3
$2.12M Buy
232,207
+34,574
+17% +$351K 0.01% 598
2023
Q2
$2.09M Sell
197,633
-76,921
-28% -$910K 0.01% 629
2023
Q1
$3.36M Sell
274,554
-53,364
-16% -$666K 0.02% 480
2022
Q4
$4.07M Buy
327,918
+46,004
+16% +$669K 0.03% 420
2022
Q3
$3.85M Buy
281,914
+186,640
+196% +$2.88M 0.04% 378
2022
Q2
$1.75M Sell
95,274
-85,809
-47% -$1.23M 0.02% 506
2022
Q1
$2.91M Sell
181,083
-27,887
-13% -$403K 0.02% 515
2021
Q4
$2.93M Buy
208,970
+91,758
+78% +$1.49M 0.02% 544
2021
Q3
$2.19M Buy
117,212
+864
+0.7% +$16.3K 0.02% 615
2021
Q2
$2.43M Buy
116,348
+3,406
+3% +$84.6K 0.02% 620
2021
Q1
$3.19M Buy
112,942
+90,544
+404% +$2.86M 0.02% 450
2020
Q4
$732K Sell
22,398
-6,207
-22% -$218K 0.01% 597
2020
Q3
$876K Buy
28,605
+16,111
+129% +$356K 0.01% 594
2020
Q2
$204K Buy
+12,494
New +$180K ﹤0.01% 926
2020
Q1
Sell
-21,551
Closed -$296K 717
2019
Q4
$296K Sell
21,551
-38,307
-64% -$568K ﹤0.01% 793
2019
Q3
$908K Buy
59,858
+38,409
+179% +$684K 0.01% 563
2019
Q2
$422K Sell
21,449
-9,079
-30% -$151K 0.01% 718
2019
Q1
$506K Buy
+30,528
New +$470K 0.01% 670

Other funds holding KURA